Stock NNVC NANOVIRICIDES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar NanoViricides, Inc.

Equities

NNVC

US6300873022

Market Closed - Nyse
Other stock markets
 21:00:00 28/06/2024 BST 		5-day change 1st Jan Change
1.72 USD -0.58% Intraday chart for NanoViricides, Inc. -5.49% +68.63%
06-20 Nanoviricides, Inc. Reports Nv-387 Is Effective in Protecting Lungs from Damage in Lethally Infected Animal Model CI
06-11 Nanoviricides, Inc. Reports Clinical Stage Lead Nanoviricide Broad-Spectrum Antiviral Drug Candidate Orally Administered Nv-387 Results in Ideal Flat Blood Concentration Profile for Sustained Antiviral Effect CI

Chart calendar NanoViricides, Inc.

a4c0f377c0eedadddf80f71099ddfc23.X5Pm93yMkdmkxO8tLkikcZ1qWluxutN_NknW5ndlj_c.Pd3QkzPr0OzcgosdHx_7AuQHHwKD34QFQwigow0p_Jsbw43PEPb3nMaztg~08e4e185b91bb30ab3dca630fcb9f5d2

Upcoming events on NanoViricides, Inc.

17/11/2024 Q3 2024 Earnings Release (Projected)
23/11/2025 Q3 2025 Earnings Release (Projected)
22/11/2026 Q3 2026 Earnings Release (Projected)

Past events on NanoViricides, Inc.

14/05/2024 EF Hutton Investor Conference
15/02/2024 11:30 Q2 2024 Earnings Release
12/01/2024 Annual General Meeting
09/01/2024 23:30 Biotech Conference
14/11/2023 Q3 2023 Earnings Release
16/10/2023 23:07 Partnership Opportunities in Drug Delivery Conference
05/06/2023 20:15 BIO International Convention
09/05/2023 EF Hutton Global Conference
09/05/2023 EF Hutton Global Conference
14/02/2023 Q1 2023 Earnings Release
09/01/2023 18:30 Biotech Conference
16/12/2022 Annual General Meeting
06/12/2022 19:00 RHK Capital Disruptive Growth Conference
17/05/2022 11:45 Q3 2022 Earnings Release
19/11/2021 Annual General Meeting
04/12/2020 Annual General Meeting
03/09/2020 16:20 LD Micro Conference
21/07/2020 19:10 B. Riley FBR Virtual Infectious Disease Summit - Panel
22/04/2020 23:40 Planet MicroCap Showcase
15/03/2020 Annual General Meeting

Annual results

Fiscal PeriodJune 2019 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00


0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00


0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-8,66
-9,70
10.72%		0,00


0,00
0,00
- 		-8,94
-7,02
-27.35%
-7,45

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-8,42
-9,50
11.32%		0,00


0,00
0,00
- 		-8,59
-7,00
-22.69%
-8,70

Net income
Million USD		Released
Forecast
Spread 		-8,42
-9,50
11.32%		-8,82


0,00
0,00
- 		-8,59
-6,69
-28.36%
-7,20

EPS
USD		Released
Forecast
Spread 		-2,40
-2,60
7.69%		-0,81


-0,70
-0,78
10.26%		-0,74
-0,43
-72.09%
-0,62

Announcement Date23/08/1912/10/2113/10/2213/10/23-

Quarterly results

Fiscal PeriodJune 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread

















0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-1,79
-2,50
28.48%		-1,79
-2,60
31.05%		-1,62
-2,00
18.88%








-2,18
-2,30
5.01%		-1,91
-2,30
17.03%
-2,40

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-1,79
-2,50
28.29%		-1,78
-2,60
31.54%		-1,57
-2,00
21.47%








-2,11
-2,20
3.87%		-1,85
-2,20
15.71%
-2,30

Net income
Million USD		Released
Forecast
Spread 		-1,79
-2,50
28.29%		-1,78
-2,60
31.54%		-1,57
-2,00
21.47%





-1,97


-2,11
-2,20
3.87%		-1,85
-2,20
15.71%
-2,30

EPS
USD		Released
Forecast
Spread 		-0,16
-0,22
27.27%		-0,15
-0,23
34.78%		-0,14
-0,17
17.65%		-0,15
-0,16
6.25%		-0,15
-0,17
11.76%		-0,17


-0,18
-0,19
5.26%		-0,16
-0,19
15.79%
-0,20

Announcement Date16/05/2213/10/2214/11/2214/02/2315/05/2314/11/2314/02/2415/05/24-

Upcoming sector events for NanoViricides, Inc.

23/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
24/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 06:00 ARGENX SE: Q2 2024 Earnings Release
29/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for NanoViricides, Inc.

05/06/2024 08:51 PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
17/05/2024 12:00 AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 12:46 BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 06:00 ZEALAND PHARMA A/S: Q1 2024 Earnings Release
15/05/2024 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
15/05/2024 13:05 THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 12:00 CABALETTA BIO, INC.: Q1 2024 Earnings Release
14/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
14/05/2024 21:05 ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 21:00 ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. NNVC Stock
  4. Calendar NanoViricides, Inc.